Greg Levine, co-chair of the Life Sciences Practice Group, focuses his practice on FDA regulation of pharmaceuticals, biotechnology and medical devices. He also counsels his pharmaceutical and medical device clients on compliance with health care fraud and abuse laws. Greg regularly represents clients before state and federal regulators on all phases of product life cycle and assists clients with both internal and government compliance investigations and enforcement actions.

Prior to joining Ropes & Gray, Greg was a partner at an international law firm in Washington, D.C. He is also a former legislative staff member in the U.S. House of Representatives, where he worked on FDA-related legislation, policy, and appropriations.